CLINICAL_TRIALS
trial_result
· 2024-03-28
Clinical Trial Update: AMG 334 20160172 Pediatric Migraine PK Study. [Phase 1]
Summary
The update reports the completion of a Phase 1 pediatric pharmacokinetic study of AMG 334 (erenumab) for migraine, with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2024-03-28